| Whitney Wright Mattes, MD | |
|
1519 3rd St Se Ste 230, Puyallup, WA 98372-3742 | |
| (253) 841-9640 | |
| (253) 841-7645 |
| Full Name | Whitney Wright Mattes |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 1519 3rd St Se Ste 230, Puyallup, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699208322 | NPI | - | NPPES |
| 2080961 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD61277116 (Washington) | Primary |
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians.
In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.
Mayo Clinic and Acorda Therapeutics, Inc. today announced that the first patient has been enrolled in the first clinical trial of rHIgM22, a remyelinating antibody being studied for the treatment of multiple sclerosis.
Physicians attribute 26 percent of overall healthcare costs to the practice of defensive medicine according to a study released today by Gallup and Jackson Healthcare.
The American Association for Cancer Research Frontiers in Cancer Prevention Research Conference will focus on the latest biological, medical and social research behind cancer prevention.
› Verified 5 days ago
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689612954 PECOS PAC ID: 0244138196 Enrollment ID: O20031230000187 |
News Archive
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians.
In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.
Mayo Clinic and Acorda Therapeutics, Inc. today announced that the first patient has been enrolled in the first clinical trial of rHIgM22, a remyelinating antibody being studied for the treatment of multiple sclerosis.
Physicians attribute 26 percent of overall healthcare costs to the practice of defensive medicine according to a study released today by Gallup and Jackson Healthcare.
The American Association for Cancer Research Frontiers in Cancer Prevention Research Conference will focus on the latest biological, medical and social research behind cancer prevention.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Whitney Wright Mattes, MD Po Box 5299, Ms: 820-5-pco, Tacoma, WA 98415-0299 Ph: (253) 459-8009 | Whitney Wright Mattes, MD 1519 3rd St Se Ste 230, Puyallup, WA 98372-3742 Ph: (253) 841-9640 |
News Archive
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians.
In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.
Mayo Clinic and Acorda Therapeutics, Inc. today announced that the first patient has been enrolled in the first clinical trial of rHIgM22, a remyelinating antibody being studied for the treatment of multiple sclerosis.
Physicians attribute 26 percent of overall healthcare costs to the practice of defensive medicine according to a study released today by Gallup and Jackson Healthcare.
The American Association for Cancer Research Frontiers in Cancer Prevention Research Conference will focus on the latest biological, medical and social research behind cancer prevention.
› Verified 5 days ago
Dr. Cholwoo Anthony Kim, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1519 3rd St Se, Ste 230, Puyallup, WA 98372 Phone: 253-841-9640 Fax: 253-841-7645 | |
Dr. Douglas R. King, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1519 3rd St Se, Ste 230, Puyallup, WA 98372 Phone: 253-841-9640 Fax: 253-841-7645 | |
Dr. Kenneth A. Feucht, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1519 3rd St Se, Ste 230, Puyallup, WA 98372 Phone: 253-445-1844 Fax: 253-841-9701 | |
Brian Nelson, Surgery Medicare: Accepting Medicare Assignments Practice Location: 208 17th Ave Se, Puyallup, WA 98372 Phone: 253-840-1999 | |
Dr. Chia J. Chung, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 105 27th Ave Se, Puyallup, WA 98374 Phone: 253-848-8110 Fax: 253-845-3561 | |
Miles Mcbride Dale, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1519 3rd St Se Ste 230, Puyallup, WA 98372 Phone: 253-841-9640 Fax: 253-841-7645 | |
Robert Charles Wright, MD FACS Surgery Medicare: Accepting Medicare Assignments Practice Location: 208 17th Ave Se, Suite 201, Puyallup, WA 98372 Phone: 253-840-1999 Fax: 253-445-4125 |